This article is more than 5 years old. Information may no longer be current.

Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)

Issue: November/December 2019

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Breast Cancer.

Subscribe

Added to email alerts

You've successfully added Breast Cancer to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Breast Cancer to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Phase 1, interventional, open-label study of GAP T cells for patients with GPC3-positive liver cancers.